Health
COVID vaccines focus on the spike protein – but here’s another target – The Conversation UK
New research shows why the N protein might be a good target.
The latest results from the phase 3 COVID-19 vaccines trials have been very positive. These have shown that vaccinating people with the gene for SARS-CoV-2 spike protein can induce excellent protective immunity.
The spike protein is the focus of most COVID-19 vaccines as it is the part of the virus that enables it to enter our cells. Virus replication only happens inside cells, so blocking entry prevents more virus being made. If a person has antibodies that can recognise the spike protein, this…
-
Noosa News14 hours agoToombul Shopping Centre site thrown lifeline after Mirvac announces sale with ‘priority’ to build new retail centre
-
General14 hours agoAllegations against ex-Attorney-General Mark Dreyfus removed from Linda Reynolds action against Commonwealth
-
Noosa News16 hours agoMirvac to sell site to Irvine Group
-
Noosa News19 hours agoTeenager faces sentencing hearing after pleading guilty to murder of Vyleen White at Ipswich shopping centre